Literature DB >> 8701560

Urodynamics and multiple sclerosis.

J L Hinson1, T B Boone.   

Abstract

Multiple sclerosis is an enigmatic and devastating neurologic disease. Voiding dysfunction is common and the irritative and obstructive symptoms can be disabling to the patient. Voiding symptoms alone are unreliable predictors of bladder and urethral dysfunction secondary to multiple sclerosis. This article focuses on the central role played by urodynamic studies in the initial assessment and management of the lower urinary tract. Detrusor hyperreflexia is the most common urodynamic finding. However, a variety of urodynamic patterns can be seen and voiding function may change over time with this chronic neurologic disorder.

Entities:  

Mesh:

Year:  1996        PMID: 8701560     DOI: 10.1016/s0094-0143(05)70326-8

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  11 in total

1.  Urologic manifestations of multiple sclerosis: proposed treatment algorithms.

Authors:  G A Barbalias; E N Liatsikos; C Passakos; D Barbalias; G Sakelaropoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Clinical management of the neurourological syndrome associated with multiple sclerosis and correlations to grade of the disease.

Authors:  G A Barbalias; E N Liatsikos; C Passakos; D Barbalias; G Sakelaropoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Neurogenic Causes of Detrusor Underactivity.

Authors:  Brian T Kadow; Pradeep Tyagi; Christopher J Chermansky
Journal:  Curr Bladder Dysfunct Rep       Date:  2015-09-15

4.  Vesicourethral dysfunction associated with multiple sclerosis: correlations among response, most prevailing clinical status and grade of the disease.

Authors:  G A Barbalias; E N Liatsikos; C Passakos; D Barbalias; G Sakelaropoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

5.  Algorithms for the management of overactive bladder.

Authors:  Richard T Kershen
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

Review 6.  Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients.

Authors:  Giulio Del Popolo; Giovanni Panariello; Francesca Del Corso; Giuseppe De Scisciolo; Giuseppe Lombardi
Journal:  Neurol Sci       Date:  2008-12       Impact factor: 3.307

7.  The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS).

Authors:  R M Freeman; O Adekanmi; M R Waterfield; A E Waterfield; D Wright; J Zajicek
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-22

Review 8.  Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis.

Authors:  Chiara Zecca; Letizia Panicari; Giulio Disanto; Paolo Maino; Anand Singh; G Alessandro Digesu; Claudio Gobbi
Journal:  Int Urogynecol J       Date:  2015-08-06       Impact factor: 2.894

9.  THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study.

Authors:  Giorgia Teresa Maniscalco; R Aponte; D Bruzzese; G Guarcello; V Manzo; M Napolitano; O Moreggia; F Chiariello; C Florio
Journal:  Neurol Sci       Date:  2017-10-19       Impact factor: 3.307

Review 10.  Female neurogenic vesicourethral dysfunction: evaluation and management.

Authors:  Rebecca J McCrery; Rodney A Appell
Journal:  Curr Urol Rep       Date:  2005-09       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.